Egypt opened The first integrated factory in the Arab world dedicated to producing rapid diagnostic tests on Sunday, July 26.
The project is designed for Enhance Local medical manufacturing, reducing dependence on imports, and supporting export expansion.
The factory, owned by Spectrum Diagnostic Industries, was opened with investments of $16.55 million (839 million pounds). Data From the Ministry of Investment and Foreign Trade.
The attachment is falls In the Ismailia Public Free Zone, with an area of 1,994 square metres, it is expected to create 38 job opportunities.
It will It works Through 2050, support Egypt’s broader strategy to localize advanced technology-based industries and increase local production of diagnostic supplies used for vital public health purposes.
Minister of Investment and Foreign Trade Mohamed Farid He said The project is in line with the government’s priorities to attract investment into strategic industrial sectors due to their strong growth potential and their role in enabling technology transfer and deepening local manufacturing capabilities.
he He added He stressed that the Ministry continues to improve the investment climate by providing comprehensive support to investors, with a focus on technology and innovation-based industries.
As Minister of Industry Khaled Hashem said described This facility is a strategic step towards localizing the production of rapid tests used to detect infectious diseases and epidemics, aid in drug screening, and identify cancer biomarkers.
Hashem is farther away male Local production is expected to reduce reliance on imported diagnostic tests, achieving annual import savings estimated at US$30 million (one billion Egyptian pounds), while also creating opportunities to expand exports of higher value medical products.
During the event, the ministers toured the factory’s new production line and reviewed the advanced manufacturing techniques used in producing rapid diagnostic tests, and highlighted the coordinated approach between the Ministries of Industry, Health and Investment, the Egyptian Drug Authority and the private sector to enhance the pharmaceutical and medical industries in Egypt.